Stay updated on Nivolumab +/- Ipilimumab in NECs Clinical Trial
Sign up to get notified when there's something new on the Nivolumab +/- Ipilimumab in NECs Clinical Trial page.

Latest updates to the Nivolumab +/- Ipilimumab in NECs Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now indicates that enrollment is closed for the study, and it adds new guidance sections to help users understand and join studies, while updating the Intervention/Treatment header formatting and revision version.SummaryDifference0.4%

- Check19 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a recent maintenance update to the site. The study details and displayed information remain the same.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision: v3.5.4 was added, replacing v3.5.3. This signals a small update to the page metadata rather than a substantive content change.SummaryDifference0.1%

- Check48 days agoChange DetectedThe reference to the NIPINEC publication has been updated to show the final JCO article details (April 20, 2026; 44(12):1120-1129) with the DOI, replacing the previous online-ahead-of-print citation.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision: v3.5.3 replaces v3.5.2, indicating a minor release/version update on the page. This change is metadata and does not affect user-facing content.SummaryDifference0.1%

- Check69 days agoChange DetectedThe page’s revision label has been updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Nivolumab +/- Ipilimumab in NECs Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab +/- Ipilimumab in NECs Clinical Trial page.